The interaction test between CD8 status and tamoxifen treatment for relapse-free interval showed a trend (P interaction = 0.082).
← all excerpts
Prognostic Impact of Immunoglobulin Kappa C (<i>IGKC</i>) in Early Breast Cancer.
1
—
—
The interaction test between CD8 status and tamoxifen treatment for relapse-free interval showed a trend (P interaction = 0.082).